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http://dx.doi.org/10.1016/j.pedneo.2Objective: To clarify the epidemiology of asthma admission in a nationwide survey, we analyze
the characteristics of hospitalized patients in Taiwan.
Methods: Data regarding asthma-associated hospitalizations were obtained from the National
Health Insurance Research Database of Taiwan from January 2001 to December 2002. Patient
characteristics in terms of severity, mortality, and cost were stratified by age, gender, and
presence of comorbidities.
Results: A total of 59,983 hospitalizations with International Classification of Diseases, Ninth
Revision, Clinical Modification (ICD-9-CM) code 493.xx and asthma-related treatment were in-
cluded in the current analysis. When stratified by age, the number and duration of hospitali-
zations were distributed in J-shape distribution, with the nadir located in the range of 8e18
years of age. The severity of asthma was found to increase with age (p < 0.001) and was more
severe in men compared with women (p < 0.001). The severity of in-hospital patients was sig-
nificantly greater in subjects with underlying respiratory disease compared to patients with
other comorbidities, such as cardiovascular disease and infectious disease. The mortality rates
of all hospitalized asthma patients and pediatric hospitalized asthma patients were 0.77% and
0.02%, respectively. The risk factor for mortality of asthma was older age and male gender in
multiple regression.
Conclusion: The severity of asthma increased after 18 years of age. Increased comorbidities
in elderly patients might contribute to asthma severity. The mortality rate was low in pediatric
patients and significantly increased in males and the elderly. The above findingsof Pediatrics, National Taiwan University Hospital, Number 7, Chung-Shan South Road, Taipei 10002,
tw (B.-L. Chiang).
an Pediatric Association. Published by Elsevier Taiwan LLC. All rights reserved.
013.01.017
Epidemiology of asthma admission 255suggest that additional effort is required in the treatment of elderly and male asthmatic
patients.
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reserved.1. Introduction
Asthma presents as chronic inflammation and obstruction of
small and middle airways. It is prevalent in all age groups
and is an important cause of morbidity and mortality
worldwide. It is estimated that approximately 300 million
people in the world have asthma, reported by the 2004
Global Initiative for Asthma (GINA).1 The cost of hospital
admissions associated with asthma make up a significant
portion of public health resources.2 In addition, asthma can
adversely impact on a patient’s overall quality of life.2 In
order to reduce hospitalizations associated with asthma,
a better understanding of the characteristics of these pa-
tients is necessary.
In the past decade, an increased rate of hospitalizations
due to asthma has been noted among children, young
adults, and the elderly.3e5 Differences in patients hospi-
talized as a result of asthma by age and sex have been
suggested in the literature.6e8 However, a comprehensive
analysis of disease severity, cost, mortality, and the pres-
ence of comorbidities is not available. The current study
identified the characteristics of patients with asthma in
terms of severity, cost, and mortality. These characteristics
were stratified by sex, age, and the presence of comor-
bidities. These data are critical for clinicians as a guide for
the distribution of public health resources when treating
patients with asthma.
On March 1, 1995, a national health insurance (NHI)
program was launched by the government of Taiwan. As of
2007, 22.60 million out of a population of 22.96 million
(greater than 98% of the Taiwan population) were enrolled
in the NHI program. For the current analysis, inpatient
claims from patients with asthma were collected from the
National Health Research Institutes of Taiwan from January
2001 to December 2002.92. Methods2.1. Study population
During the period from January 2001 to December 2002,
64,545 hospitalized patients from the Taiwan National
Health Insurance Research Database were identified as
potential cases of asthma according to the International
Classification of Diseases, Ninth Revision, Clinical Mod-
ification (ICD-9-CM) code (493.xx). Patients were excluded
if they were younger than 2 years of age, charged for
surgery, and without treatment-associated asthma. All
other hospitalizations were considered asthma-
associated. In total, 59,983 inpatients were enrolled in
the study.2.2. Categorization of data and measurement of
disease severity
The severity of asthma in all hospitalized patients was
categorized by age (2e7 years, 8e18 years, 19e40 years,
41e60 years, and over 61 years, respectively), sex (male or
female), and the presence of comorbidities (with or with-
out any comorbidity). A total of six parameters of disease
severity were analyzed: duration of hospitalization, cost of
hospitalization, rate of intubation, use of ventilator (non-
invasive and invasive), use of magnesium sulfate (MgSO4),
and mortality rate.
2.3. Comorbidity analysis
Patient comorbidities were grouped according to the ICD-9-
CM classification. The six most frequent comorbidities
associated with mortality were, in decreasing order, respi-
ratory disease, cardiovascular disease, endocrine disease,
gastrointestinal disease, genitourinary disease, and infec-
tious disease. The defined respiratory diseases include acute
respiratory infection (ICD-9 code 460-466), other disease of
the upper respiratory tract (ICD-9 code 470-478), pneumonia
and influenza (ICD-9 code 480-488), and chronic pulmonary
diseases (ICD-9 code 490-519). The defined cardiovascular
diseases include rheumatic heart diseases (ICD-9 code 390-
398), hypertensive diseases (ICD-9 code 401-405), ischemic
heart diseases (ICD-9 code 410-414), diseases of the pul-
monary circulation and other forms of heart diseases (ICD-9
code 415-429), cerebrovascular diseases (ICD-9 code 430-
438), and disease of arteries, veins, and lymphatics (ICD-9
code 440-459). The defined endocrine diseases include dis-
ease of the thyroid gland and other endocrine glands (ICD-9
code 240-246, 249-259), nutrition, metabolic and immunity
disorders (ICD-9 code 260-279), and disease of the blood and
blood-forming organs (ICD-9 code 280-289). The defined
gastrointestinal diseases include disease of the oral cavity,
salivary glands, and jaws (ICD-9 code 520-529) and other
gastrointestinal diseases (ICD-9 code 530-579). The defined
genitourinary diseases include urinary system diseases (ICD-
9 code 580-599), male genital organ diseases (ICD-9 code
600-608), diseases of the breast (ICD-9 code 610-611), and
female genital organ diseases (ICD-9 code 614-629). The
defined infectious diseases include intestinal infectious
diseases (ICD-9 code 001-009), tuberculosis (ICD-9 code 010-
018), bacterial infection (ICD-9 code 020-027,030-041),
human immunodeficiency virus (HIV) infection (ICD-9 code
042-044), other viral diseases (ICD-9 code 046-054, 056-079),
rickettsioses and other arthropod-borne diseases (ICD-9
code 080-088), other sexual transfusion diseases (ICD-9 code
090-099), and other infection and parasitic diseases (ICD-9
code 100-136,139). A hospitalization event with any
diagnosis of cardiovascular disease was defined as
Figure 1 The severity of all asthma patients in different age
groups with different parameters.
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ease. The same rule was also applied to other analyzed
comorbidities. It is to be noted that a single hospitalization
event may contribute to more than one comorbidity. The
mortality rate was calculated and compared among the six
comorbidity groups.
2.4. Mortality
Mortality was defined according to the discharge status
recorded in the NHI research database. The mortality
events were divided into two groups: “death from asthma”
and “death with asthma”. Death from asthma was defined
as a mortality event with only asthma as the discharge
diagnosis (ICD-9-CM code 493.xx). Death with asthma was
defined as mortality events with asthma or any other dis-
ease at the time of discharge.
2.5. Statistical analysis
All data were analyzed using SPSS software (SPSS 17.0, SPSS
Inc., Chicago, IL, USA). Duration and cost of asthma are
expressed as means (SE). Intubation rate, mortality rate,
ventilator support, and MgSO4 usage are presented as
a percentage. Asthma severity was compared using an in-
dependent t test and Chi-square (significance defined as
p < 0.001). Multiple logistic regression was used to estimate
the adjusted odds ratios (ORs) and a 95% confidence in-
terval (CI) was used to present the risk of different
comorbidities in patients with asthma.
3. Results
3.1. Patient characteristics
From January 2001 to December 2002, a total of 59,983
patients were hospitalized due to events associated with
asthma. The average patient was aged 51.88 years. The
majority of patients were men (55.66%). The average
duration of hospitalization was 7.17  0.06 days and wasTable 1 Baseline patient characteristics stratified by age.
Group 1 2 3




Female (n) 3636 1041 2624
Male (n) 5988 1671 3485
Duration of hospital stay
(days)y
3.47  0.02 3.40  0.05 5.42
Cost (USD)y 294.27  1.95 308.19  12.21 471.
Intubation, n (%) 14 (0.15) 20 (0.74) 112
Mortality, n (%) 0 (0) 3 (0.11) 6 (0.
Using ventilator, n (%) 19 (0.20) 39 (1.44) 268
Using MgSO4, n (%) 3 (0.0) 5 (0.18) 49 (0
*p < 0.001 (compare groups 4 and 5).
MgSO4 Z magnesium sulfate; SE Z standard error.
y The duration of hospital stay and cost are shown as mean  standassociated with an average cost of 668.68  6.28 US dollars.
The total mortality rate was 0.77% (Table 1).
3.2. Severity of asthma in patients stratified by age
When stratified by age, the number of hospitalizations
associated with asthma revealed a J-shape distribution,
with the nadir located at the group of 8e18 years of age.
After the age of 18 years, the number of hospitalizations
significantly increased. The duration of hospitalization
showed a similar J-shaped distribution, although with a less
prominent trend. The average cost of hospitalization
increased in association with increasing age. The rate of
intubation, use of ventilator, intravenous magnesium sul-
fate use, and mortality rate also increased with advanced
age (Table 1, Figure 1). The severity of asthma was sig-
nificantly increased in the elderly (comparing age groups 4
and 5, p < 0.001).
3.3. Severity of asthma in gender analysis
A total of 55.66% of the study population were men. The





 0.06 6.73  0.09* 9.19  0.10* 7.17  0.06
54  6.13 616.55  9.57* 878.84  11.63* 668.68  6.28
(1.83) 243 (2.17)* 1315 (4.34)* 1704 (2.84)
10) 34 (0.30)* 420 (1.39)* 463 (0.77)
(4.39) 569 (5.07)* 2355 (7.77)* 3250 (5.42)
.80) 111 (0.99)* 222 (0.73)* 390 (0.65)
ard error (SE).
Table 2 Baseline patient characteristics stratified by sex.
Female Male Total p
Total no. of hospitalizations, n (%) 26,596 (44.34) 33,387 (55.66) 59,983
Age (y)
2e7 3636 5988 9624
8e18 1041 1671 2712
19e40 2624 3485 6109
41e60 6283 4941 11,224
61þ 13,012 17,302 30,314
Duration of hospital stay (days)z 7.35  0.09 7.02  0.07 0.000*
Cost (USD)z 707.20  10.35 638.00  7.70 0.000*
Intubation, n (%) 745 (2.80) 959 (2.87) 0.602
Mortality, n (%) 158 (0.59) 305 (0.91) 0.000y
Using ventilators, n (%) 1460 (5.48) 1790 (5.36) 0.490
Using MgSO4, n (%) 189 (0.71) 201 (0.60) 0.100
MgSO4 Z magnesium sulfate; SE Z standard error.
* t test.
y Chi-square test.
z The duration of hospital stay and cost are shown as mean  standard error (SE).
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nificantly increased rate of mortality (p < 0.001) (Table 2).
Gender is a risk factor of mortality of asthma under mul-
tiple regression (p < 0.001).
3.4. Comorbidity analysis
The most common comorbidities associated with asthma
patients were respiratory disease, cardiovascular disease,
endocrine disease, gastrointestinal disease, genitourinary
disease, and infectious disease. The risk of mortality,
intubation, and use of a ventilator were statistically sig-
nificantly increased for all comorbidities analyzed except
for gastrointestinal disease (Table 3). The risk of mortality
and the use of a ventilator were associated with the fol-
lowing comorbidities (in decreasing order): respiratory
disease, infectious disease, endocrine disease, genito-
urinary disease, and cardiovascular disease. For the risk of
intubation, a similar order was found (Table 3). The above
results suggested that many concurrent diseases were






Respiratory disease 3.543 2.916e4.306* 5.222 4.67
Cardiovascular
disease
1.691 1.401e2.042* 1.718 1.55
Endocrine disease 1.886 1.540e2.309* 1.595 1.42
Gastrointestinal
disease
1.114 0.895e1.385 1.035 0.91
Genitourinary
disease
1.801 1.440e2.251* 1.534 1.35
Infection 2.545 1.993e3.252* 2.415 2.10
Neoplasm 2.952 1.927e4.522* 2.211 1.69
*p < 0.001.
yp < 0.05.hospitalization. Comorbidity was also associated with
increased duration of hospitalization and cost (Table 4).
3.5. Analysis of patients with a single diagnosis of
asthma
We also analyzed hospitalization without any comorbidity. A
total of 11,733 patients were analyzed who presented with
asthma and no comorbidities. The number, duration, and
cost of admission showed a J-shaped distribution for each
age group, with the nadir located in the range of patients
aged 8e18 years (Figure 2). The intubation rate and ven-
tilator usage also increased with advanced age (Figure 2).
The mortality only showed in group 5. A total of 59.58% of
patients were men. The duration, cost, intubation rate, and
mortality rate were significantly higher in males (p < 0.05).
3.6. Analysis of mortality
Among those patients who died from asthma while in the






7e5.831* 5.172 4.773e5.605* 1.354 1.106e1.657y
3e1.900* 1.584 1.469e1.707* 1.131 0.915e1.397
4e1.786* 1.610 1.479e1.753* 1.501 1.191e1.892*
9e1.166 0.996 0.911e1.088 0.785 0.604e1.091
1e1.742* 1.594 1.449e1.753* 1.159 0.874e1.536
7e2.767* 2.340 2.108e2.597* 1.722 1.280e2.316*
0e2.891* 1.559 1.237e1.965* 1.800 1.032e3.141*
Table 4 Mortality analysis (single diagnosis with asthma,
















15.45  4.48 32.55  4.31
Cost (USD)* 3302.88  1210.03 3989.22  380.61
* The duration of hospital stay and cost are shown as
mean  standard error (SE).
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tients were distributed through all age groups, except for
those patients aged 2e7 years. The mortality rates of all
hospitalized asthma patients and pediatric hospitalized
asthma patients (2e18 years old) were 0.77% and 0.02%,
respectively. The number of deaths with asthma increased
with age. In multiple regression for risk factors of mortal-
ity, age, gender, intubation, and ventilator were signifi-
cant, whereas comorbidity was not.
4. Discussion
In the current study, the number of hospitalizations
associated with asthma among age groups revealed
a J-shaped distribution, with the nadir located in patients
aged 8e18 years. Several studies have demonstrated
similar results. Hsieh et al (2009) demonstrated that the
distribution of pediatric patients with asthma in the ICU
showed a nadir at 6e12 years.10 In another study, the
distribution of hospital admissions stratified by age
showed the nadir in the group aged 13e18 years.8 BarcalaFigure 2 The severity of single diagnosis of asthma patients
in different age groups with different parameters.et al (2010) also showed the number of hospital admis-
sions was lower in the group aged 10e14 years compared
with the group aged 0e9 years.7 Patients aged 8e18 years
may have the lowest number of hospital admissions due to
a more effective immune system, lower overall comor-
bidities compared with older patients, and a reduced
overall incidence of infections, which can induce exac-
erbations of asthma.
In a study by Huang et al (2008), in children aged 18
years or less, the average duration of hospital admission
was 3.6 days, in contrast to 8.2 days in the adult group.3 In
the United States, the median length of stay for patients
older than 65 years of age was 5e7 days.4 Average lengths
of stay in patients with a mean age of 48.5 years for women
and 44.6 years for men have been reported to be 3.44 days
and 2.84 days, respectively.6 In another study, the length of
stay for children admitted to the hospital has been repor-
ted to be 2.65 days.11 Collectively, these studies showed
that older patients with asthma required longer hospital
stays associated with asthma.
In the current study, the cost of hospitalizations
increased with advanced age, which is in agreement with
other similar studies.3 In New Zealand, the intubation rate
has been reported to be 2.1% for all age groups.12 In the
US, the intubation rate has been reported to be 3.7e4.4%
in patients with a mean age of 44.6e48.5 years.6 In the
current study, the total intubation rate was 2.8% during
hospitalization, which increased with age (Table 1). The
rate of ventilator use, mortality, and the use of MgSO4 also
increased with age. These results suggested that more
emphasis needs to be placed on education and control of
asthma in elderly patients. Some studies have shown that
elderly patients do not receive appropriate treatment of
asthma as compared with younger patients.13,14 This may
be due to the increased incidence of comorbidities in older
adults, and the subsequent treatment of other more se-
vere conditions. Comorbidities in older adults might also
increase the difficulties related to following the pre-
scribed treatment guidelines for asthma.14 Older patients
continue to present with more severe asthma despite the
lack of any comorbidities. Over the last decade, the
prevalence of asthma has increased in all age groups;
therefore, it remains critical to design asthma care pro-
grams for all age groups, especially for elderly patients
with comorbidities.
Hospitalizations in men were more common than women
in each age group currently examined, except for patients
aged 41e60 years. The main outcome measures were more
severe in men, especially in mortality rate. In other studies,
it has been also demonstrated that the admission rate in
women was greater than that observed in men, but the
intubation rate and mortality rate remained higher in men.6
More recently, a trend for increased prevalence and
severity of asthma is on the rise in boys of 7e8 years old.15
Adult males have been shown to be more likely to smoke
cigarettes and use over-the-counter asthma medications,16
habits that may cause more severe disease. By contrast,
some studies have reported that the rate of hospital visits
was higher in women.6,16 These results may be attributed to
the higher tendency of female patients to look for medical
care for asthma symptoms and possibly a higher rate of
admission in female patients. However, in another study,
Epidemiology of asthma admission 259the percentage of hospitalization was higher in men.7 In
women aged 41e60 years in the current study, the number
of hospitalizations was more than that observed in men.
The observed difference may be due to a change in sex
hormones, although the exact mechanism remains to be
elucidated.
In the current study, a total of 463 mortality events
(0.77%) were recorded, which was similar to a previous
report in Portugal where the number of patients who died
with asthma was greater than the number who died from
asthma.8 Comorbidities of disease may cause asthma to be
more severe resulting in increased death, especially among
older patients. In many studies, it has been demonstrated
that the mortality rate increased with advanced age
despite the presence of comorbidities.7e20 In the current
study, no mortality event was defined as “death from
asthma” in any patient aged below 60 years; another study
reported the existence of death resulting from asthma in
patients aged 60 years or less (rate of mortality for 45e64
years old was 1.5 per 100,000 during 2002e2003).17 One
possible explanation for this phenomenon is that the cur-
rent study focused on hospitalized patients, and patients
who died who were treated in clinics or emergency de-
partments may not be included in the current analysis.
Another possible explanation is that asthma was fairly
controlled in patients aged 60 years or younger due to
higher functional status and improved self-care. Accord-
ingly, more intensive care and education for asthma is
indicated for patients with asthma who are aged 60 years or
greater, regardless of the presence of comorbidities. The
mortality rate associated with asthma has declined in
recent years due to the improvement of asthma care pro-
grams and medical treatment.21,22 No evidence has been
reported that reveals a trend towards increased mortality
associated with asthma in Taiwan, although this warrants
additional study.
The presence of comorbidities in patients hospitalized as
a result of asthma was analyzed in the current study.
Leander et al (2010) showed that the causes of death most
commonly associated with asthma were cardiovascular
disease, cancer, and respiratory disease.19 This is supported
by Fuhrman et al, who demonstrated that cardiovascular
disease, neoplasm, and respiratory disease were the most
common comorbidities in older patients.17 In some studies,
endocrine disease, gastrointestinal disease, and genito-
urinary disease were also found to be associated.23e25
There are many comorbidities contributing different ef-
fects for asthma, so adjusted ORs for common comorbid-
ities was done in the study. In the current OR analysis of
comorbidities, the most common comorbidity associated
with asthma was respiratory disease. It is interesting that
infectious disease, endocrine disease, and genitourinary
disease but not cardiovascular disease were the most
common comorbidities in patients with asthma in the cur-
rent study. Many studies have emphasized the importance
of neoplasms; therefore, the risk of neoplasm was also
analyzed. The odds ratio of mortality among patients with
neoplasm was significantly higher; however, an explanation
for this association has not been established. In addition,
gastrointestinal disease was not significantly associated
with increased asthma severity (Table 3). Patients with
asthma who have comorbidities require comprehensivecare to control their disease, as evidenced by the currently
reported outcomes.
There are several limitations worth noting in the current
study. Only hospitalized patients from the National Health
Research Institutes, Taiwan database were included. The
inclusion of patients from emergency rooms without admis-
sion would have impacted on the scope of these results.
Secondly, because this study was a retrospective analysis
based on discharge diagnosis, there is no information
regarding the standardization of each diagnosis. However,
this limitationwas noted throughout studies of the database.
Thirdly, we did not extend the analysis to population-based
data in Taiwan in order to demonstrate a more detailed
epidemiology. Finally, in this database, the presence of
baseline conditions and any ongoing medication use not
covered by insurance of the same admission could not be
determined.
In summary, with respect to the number, duration, cost,
intubation rate, and mortality of patients with asthma who
were admitted to hospitals, increasing age (greater than 18
years) was associated with significantly increased severity.
Increased comorbidities may also play a role in increased
severity of asthma in elderly patients. The mortality rate
was low in pediatric patients and significantly increased in
males and the elderly. Taken together, improved education
for all patients with asthma should be emphasized. Efforts
towards better treatment of elderly and male patients
should be considered.Acknowledgments
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